Fortis Malar Hospitals Share Price Target 2025, 2026, 2030, 2040, 2050

Fortis Malar Hospitals is a healthcare company that is part of Fortis Hospitals. It runs a 180-bed hospital in Chennai that treats many types of health problems. This hospital was first called Malar Hospital and later became part of the Fortis group after it was bought and renamed. It offers many medical services such as heart care, brain and nerve treatment, bone and joint care, stomach and kidney treatment, women’s health, children’s health, and general medicine. The hospital provides both advanced and regular medical care.

What is Fortis Malar Hospitals Ltd. BSE: FORTISMLR?

Fortis Malar Hospitals was established in 1992 in Adyar, Chennai, and was first owned by Malar Hospitals Ltd. It is a popular hospital that offers many treatments like cancer treatment,  heart care, brain care and kidney care. In 2008, it was bought by Fortis Healthcare. The hospital had about 180 beds, including 60 ICU beds, and more than 160 doctors and 650 staff. In late 2023, it sold a 62.7% share in the hospital to MGM Healthcare Pvt Ltd for around ₹128 crore, which included the hospital building and land. The sale was completed by February 2024, and now the hospital is fully owned and managed by MGM Healthcare.

Share Price Target Tomorrow

The stock has shown a good bullish move since some previous month. But the stock could not continue and fell back. At the current time the stock has made some pattern shows that it will fall more. So you should keep an eye on it as it could give you on deep opportunity to get more profit, but consider some more confirmation because getting more profit comes with high risk.

Day	Minimum Price (Rs)	Maximum Price (Rs)
Tomorrow	-2.22	+5.50

Fortis Malar Hospitals Share price Target 2025

The company has little debt. But its financial situation is not looking great. The company isn’t making much profit, and its stock price seems too high compared to the actual value. While it pays a good dividend, its sales are dropping, and it’s having trouble making steady profits. The company has also faced issues with cash flow and managing its daily operations. So it is better to keep tracking its movement, so you can buy it at a cheap price to get more profit. In 2025, its share price target would be ₹120.05, as per our prediction.

Its share price would be between ₹56.02 to ₹120.05 in 2025, as per our analysis.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2025	56.02	120.05

Month	Minimum Price  (Rs)	Maximum Price (Rs)
January	55.15	62.80
February	56.02	61.35
March	58.60	73.80
April	70.00	98.70
May	68.20	81.00
June	70.60	77.00
July	65.28	89.56
August	70.74	97.34
September	79.34	107.65
October	86.75	111.84
November	90.57	114.65
December	95.35	120.05

Fortis Malar Hospitals Share Price Target 2026

The hospital treated many health problems like brain and nerve problems, heart issues, bone and joint pain, stomach issues, and kidney problems. It also had scanning and testing services. It is well-known for treating serious health problems, especially heart diseases. It is famous for heart surgeries like angioplasty and bypass surgery, helping many patients. The hospital offered services like dialysis, endoscopy, small cut surgeries, and emergency care for injuries. In 2026, its share price target would be ₹184.22, as per our analysis.

By our prediction, its share price would be between ₹95.35 to ₹184.22 in 2026.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2026	95.35	184.22

Month	Minimum Price  (Rs)	Maximum Price (Rs)
January	95.35	124.45
February	98.65	127.35
March	99.30	130.65
April	108.65	137.5
May	115.36	140.54
June	124.85	147.32
July	130.41	152.74
August	134.85	158.95
September	138.30	167.30
October	145.84	172.64
November	153.64	177.32
December	160.38	184.22

Share price Target 2027

It had many types of medical staff, like full-time doctors, visiting surgeons, junior doctors, and skilled nurses. Some of the best heart and general doctors in Chennai worked there, which made the hospital strong. All staff follow rules, which include regular training, using trusted medical methods, and meeting international standards. The company is also focusing more on big cities like Delhi and Mumbai to expand its services. In 2027, its share price target would be ₹245.52, as per our prediction.

Its share price would be between ₹160.38 to ₹245.52 in 2027, as per our analysis.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2027	160.38	245.52

Share price Target 2028

It focused on keeping patients safe, clean surroundings, controlling infections, and using proven medical methods. The staff got regular training, the hospital was checked, and strict steps were taken to give reliable care. It also compared its performance with other hospitals in areas like how quickly patients were sent home, how often they came back, and how safely medicines were given. In 2028, its share price target would be ₹304.67, as per our analysis.

By our prediction, its share price would be between ₹229.56 to ₹304.67 in 2028.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2028	229.56	304.67

Share price Target 2029

It follows a traditional hospital business model, which earns most of its money from patient admissions, doctor checkups, medical tests, planned surgeries, and advanced treatments like heart care. It is a large private hospital group in India. It mainly focused on attracting middle- and upper-income patients by offering both expert treatments, such as heart care, and regular outpatient services. In 2029, its share price target would be ₹367.05, as per our prediction.

Its share price would be between ₹276.36 to ₹367.05 in 2029, as per our analysis.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2029	276.36	367.05

Fortis Malar Hospitals share price Target 2030

It sold the Hospital to MGM Healthcare, a growing hospital group in Chennai. The sale included both the hospital and the land it was built. The company made this decision to focus on its bigger and better-performing hospitals. They said the sale was a good step for the company and its investors. For MGM, this was a chance to grow in South Chennai by taking over a well-known hospital with regular patients. The company then started giving that money back to shareholders and providing good treatment at the rest of its hospitals. In 2030, its share price target would be ₹427.28, as per our analysis.

By our prediction, its share price would be between ₹352.41 to ₹427.28 in 2030.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2030	352.41	427.28

Month	Minimum Price  (Rs)	Maximum Price (Rs)
January	352.41	375.32
February	356.32	378.35
March	358.41	380.34
April	360.30	382.42
May	363.64	385.31
June	366.74	388.36
July	371.68	391.64
August	376.31	398.31
September	379.32	407.31
October	384.64	413.51
November	390.64	418.64
December	399.64	427.28

Share price Target 2040

It sold Fortis Malar to focus on hospitals that grow faster and make more money. It was an older hospital with an old building and a location that made it hard to grow. By selling it, the company could use the money to invest in their main hospitals in bigger cities like Delhi, Mumbai, and Bengaluru. This also helped lower the costs and risks of running a hospital in Tamil Nadu. In 2040, its share price target would be ₹859.64, as per our prediction.

Its share price would be between ₹781.27 to ₹859.64 in 2040, as per our analysis.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2040	781.27	859.64

Month	Minimum Price  (Rs)	Maximum Price (Rs)
January	781.27	802.51
February	786.41	807.64
March	789.30	810.62
April	792.45	817.31
May	795.36	820.65
June	799.32	824.56
July	807.32	830.67
August	812.64	834.85
September	817.35	837.45
October	820.67	842.64
November	827.34	850.56
December	835.84	859.64

Share Price Target 2050

During the COVID-19 pandemic, the hospital quickly set up special rooms for COVID-19 patients, added more ICU beds, and started testing for the virus. The staff learned how to use safety equipment to protect themselves and patients. The hospital also began online doctor visits to help patients without them coming in. It worked hard and showed strong care for the community during this hard time. This proved the hospital could adjust and support people even when things were tough. In 2050, its share price target would be ₹1472.98, as per our analysis.

By our prediction, its share price would be between ₹1386.15 to ₹1472.98 in 2050.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2050	1386.15	1472.98

Month	Minimum Price  (Rs)	Maximum Price (Rs)
January	1386.15	1404.84
February	1392.41	1413.40
March	1397.65	1417.36
April	1403.65	1420.56
May	1408.35	1424.32
June	1410.74	1427.21
July	1413.45	1434.14
August	1420.85	1447.34
September	1425.32	1453.75
October	1430.54	1460.21
November	1439.64	1466.74
December	1452.73	1472.98

Should I buy Fortis Malar Hospitals stock?

Year	Minimum Price (Rs)	Maximum Price (Rs)
2025	56.02	120.05
2026	95.35	184.22
2027	160.38	245.52
2028	229.56	304.67
2029	276.36	367.05
2030	352.41	427.28
2040	781.27	859.64
2050	1386.15	1472.98

At the current time, buying its stock might not be the best choice because the company is having some financial issues. Sales are falling, profits are low, and the stock price is higher than what the company is really worth. It benefits from the well-known Fortis brand, but the company isn’t growing much. It’s better to watch the stock closely, and if the price drops, there could be an opportunity to buy it at a better price.

Fortis Malar Hospitals earnings results

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Sales +	111.87	69.24	86.18	85.95	59.01	0.00
Expenses +	114.57	75.58	82.74	81.38	60.22	2.14
Operating Profit	-2.70	-6.34	3.44	4.57	-1.21	-2.14
OPM %	-2.41%	-9.16%	3.99%	5.32%	-2.05%
Other Income +	11.11	15.10	7.39	6.64	64.88	2.72
Interest	7.81	7.20	6.56	6.07	4.30	0.01
Depreciation	12.53	12.88	12.53	12.15	9.36	0.00
Profit before tax	-11.93	-11.32	-8.26	-7.01	50.01	0.57
Tax %	-25.48%	-30.48%	0.12%	120.97%	9.36%	31.58%
Net Profit +	-8.89	-7.87	-8.27	-15.48	45.32	0.39
EPS in Rs	-4.74	-4.20	-4.41	-8.26	24.18	0.21
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	175.93%	0.00%

Key Metrics

TTM PE Ratio	PB Ratio	Dividend Yield	Sector PE	Sector PB	Sector Div Yld
350.76	1.25	—	37.15	6.59	0.81%

Peers & Comparison

Stock	PE Ratio	PB Ratio	Dividend Yield
Fortis Malar Hospitals Ltd	350.76	1.25	—
Max Healthcare Institute Ltd	117.30	15.01	0.12%
Apollo Hospitals Enterprise Ltd	75.11	14.84	0.37%
Fortis Healthcare Ltd	78.70	7.12	0.12%

Is Fortis Malar Hospital stock good to buy? (bull case & bear case)

Bull Case:

• The company has no debt, so it doesn’t owe money to lenders
• In FY24 it earn a profit of ₹45 crore after a ₹15 crore loss in FY23
• Profit margin improved a lot, with the company keeping over 75% of its earnings as profit in FY24
• It operates under the well-known Fortis healthcare brand, trusted in the medical industry
• The stock trades at around 346 times earnings, which means investors expect strong future growth
• Promoters own over 63% of the company, showing they trust the company’s future

Bear Case:

• Even though the company made profits, it doesn’t regularly pay dividends to its shareholders
• Sales have been falling, with revenue dropping 31% in FY24
• The hospital’s main business is still not strong; a lot of the profit may have come from other sources

Conclusion

The company sold most of the hospital to MGM Healthcare, and since then, it has been struggling with falling sales and low profits. But it doesn’t have much debt, the company is not making enough money, and its stock price seems too high for what the company is worth. While it benefits from the well-known Fortis brand, the hospital is not growing much. So, if you’re thinking about buying its stock, it’s important to be careful and understand the risks involved.

FAQs